Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


Last Updated: March 1, 2016; Last Reviewed: March 1, 2016

Human Papillomavirus Disease
Member Financial Disclosure
Company Relationship
Brown, Darron
Indiana University School of Medicine Merck Advisory Board, Honoraria, Patent, Speaker’s Bureau
PDS, Inc. Advisory Board
Cu-Uvin, Susan* Brown University CONRAD Advisory Board
Dunne, Eileen Centers for Disease Control and Prevention None N/A
Einstein, Mark Rutgers New Jersey Medical School Baxalta Research Support
Becton-Dickinson Research Support
Eli Lilly Research Support
Inovio Advisory Board, Research Support, Travel Support
Natera Consultant
Papivax Consultant
PDS, Inc. Consultant, Research Support, Travel Support
Photocure Consultant, Research Support, Travel Support
Roche Molecular Diagnostics Advisory Board, Travel Support
Massad, L. Stewart
Washington University School of Medicine None N/A
Moscicki, Anna Barbara University of California, Los Angeles Merck Advisory Board, Honoraria
Palefsky, Joel University of California, San Francisco Aura Biosciences Advisory Board, Travel Support
Hologic Research Support
Merck Advisory Board, Consultant, Research Support, Travel Support
Pharmajet Advisory Board
Qiagen Consultant
Stier, Elizabeth Boston University Medical Center None N/A
Strickler, Howard Albert Einstein College of Medicine BD Sciences, Arbor Vita, MTM/Roche, Norchip AS These companies providing free testing in a study of molecular methods for cervical cancer screening in HIV+ women.
Wilkin, Timothy Weill Cornell Medical College Gilead Research Support
Bristol Myers Squibb Research Support
GlaxoSmithKline/ViiV Research Support
Johnson & Johnson Spouse is employee and owns stock.
* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from March 1, 2014, through March 1, 2016.

Download Guidelines